|
1
|
Maris JM and Matthay KK: Molecular biology
of neuroblastoma. J Clin Oncol. 17:2264–2279. 1999.PubMed/NCBI
|
|
2
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharp SE, Gelfand MJ and Shulkin BL:
Pediatrics: Diagnosis of neuroblastoma. Semin Nucl Med. 41:345–353.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matthay KK, Villablanca JG, Seeger RC,
Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT,
Brodeur GM, et al: Treatment of high-risk neuroblastoma with
intensive chemotherapy, radiotherapy, autologous bone marrow
transplantation and 13-cisretinoic acid. Children's Cancer group. N
Engl J Med. 341:1165–1173. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pearson AD, Pinkerton CR, Lewis IJ, Imeson
J, Ellershaw C and Machin D; European Neuroblastoma Study Group,
Children's Cancer and Leukaemia Group (CCLG formerly United Kingdom
Children's Cancer Study Group): High-dose rapid and standard
induction chemotherapy for patients aged over 1 year with stage 4
neuroblastoma: A randomised trial. Lancet Oncol. 9:247–256. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zage PE, Kletzel M, Murray K, Marcus R,
Castleberry R, Zhang Y, London WB and Kretschmar C; Children's
Oncology Group: Outcomes of the POG 9340/9341/9342 trials for
children with high-risk neuroblastoma: A report from the Children's
Oncology Group. Pediatr Blood Cancer. 51:747–753. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lau L, Tai D, Weitzman S, Grant R,
Baruchel S and Malkin D: Factors influencing survival in children
with recurrent neuroblastoma. J Pediatr Hematol Oncol. 26:227–232.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Laverdière C, Cheung NK, Kushner BH,
Kramer K, Modak S, LaQuaglia MP, Wolden S, Ness KK, Gurney JG and
Sklar CA: Long-term complications in survivors of advanced stage
neuroblastoma. Pediatr Blood Cancer. 45:324–332. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen C, Liu J and Xu G: Overexpression of
PIWI proteins in human stage III epithelial ovarian cancer with
lymph node metastasis. Cancer Biomark. 13:315–321. 2013.
|
|
10
|
Sharma AK, Nelson MC, Brandt JE, Wessman
M, Mahmud N, Weller KP and Hoffman R: Human CD34 (+) stem cells
express the hiwi gene, a human homologue of the Drosophila gene
piwi. Blood. 97:426–434. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carmell MA, Girard A, van de Kant HJ,
Bourc'his D, Bestor TH, de Rooij DG and Hannon GJ: MIWI2 is
essential for spermatogenesis and repression of transposons in the
mouse male germline. Dev Cell. 12:503–514. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aravin A, Gaidatzis D, Pfeffer S,
Lagos-Quintana M, Landgraf P, Iovino N, Morris P, Brownstein MJ,
Kuramochi-Miyagawa S, Nakano T, et al: A novel class of small RNAs
bind to MILI protein in mouse testes. Nature. 442:203–207.
2006.PubMed/NCBI
|
|
13
|
Qiao D, Zeeman AM, Deng W, Looijenga LH
and Lin H: Molecular characterization of hiwi, a human member of
the piwi gene family whose overexpression is correlated to
seminomas. Oncogene. 21:3988–3999. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su C, Ren ZJ, Wang F, Liu M, Li X and Tang
H: PIWIL4 regulates cervical cancer cell line growth and is
involved in down-regulating the expression of p14ARF and p53. FEBS
Lett. 586:1356–1362. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu C, Qu L, Dong B, Xing X, Ren T, Zeng
Y, Jiang B, Meng L, Wu J and Shou C: Combined phenotype of 4
markers improves prognostic value of patients with colon cancer. Am
J Med Sci. 343:295–302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li D, Sun X, Yan D, Huang J, Luo Q, Tang H
and Peng Z: Piwil2 modulates the proliferation and metastasis of
colon cancer via regulation of matrix metallopeptidase 9
transcriptional activity. Exp Biol Med (Maywood). 237:1231–1240.
2012. View Article : Google Scholar
|
|
17
|
Korbecki J, Baranowska-Bosiacka I,
Gutowska I and Chlubek D: Biochemical and medical importance of
vanadium compounds. Acta Biochim Pol. 59:195–200. 2012.PubMed/NCBI
|
|
18
|
Wu Y, Ma Y, Xu Z, Wang D, Zhao B, Pan H,
Wang J, Xu D, Zhao X, Pan S, et al: Sodium orthovanadate inhibits
growth of human hepatocellular carcinoma cells in vitro and in an
orthotopic model in vivo. Cancer Lett. 351:108–116. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ipsaro JJ, Haase AD, Knott SR, Joshua-Tor
L and Hannon GJ: The structural biochemistry of Zucchini implicates
it as a nuclease in piRNA biogenesis. Nature. 491:279–283. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klein A, Holko P, Ligeza J and Kordowiak
AM: Sodium orthovanadate affects growth of some human epithelial
cancer cells (A549, HTB44, DU145). Folia Biol (Krakow). 56:115–121.
2008. View Article : Google Scholar
|
|
21
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dryer RL and Lata GF: Experimental
biochemistry. New York: Oxford University Press; New York, NY: pp.
346–347. 1989
|
|
23
|
Maris JM: Recent advances in
neuroblastoma. N Engl J Med. 362:2202–2211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee JH, Schütte D, Wulf G, Füzesi L,
Radzun HJ, Schweyer S, Engel W and Nayernia K: Stem-cell protein
Piwil2 is widely expressed in tumors and inhibits apoptosis through
activation of Stat3/Bcl-XL pathway. Hum Mol Genet. 15:201–211.
2006. View Article : Google Scholar
|
|
25
|
Wang QE, Han C, Milum K and Wani AA: Stem
cell protein Piwil2 modulates chromatin modifications upon
cisplatin treatment. Mutat Res. 708:59–68. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suwalsky M, Fierro P, Villena F, Aguilar
LF, Sotomayor CP, Jemiola-Rzeminska M, Strzalka K, Gul-Hinc S,
Ronowska A and Szutowicz A: Human erythrocytes and neuroblastoma
cells are in vitro affected by sodium orthovanadate. Biochim
Biophys Acta. 1818:2260–2270. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kordowiak AM, Klein A, Goc A and Dabroś W:
Comparison of the effect of VOSO4, Na3VO4 and NaVO3 on
proliferation, viability and morphology of H35-19 rat hepatoma cell
line. Pol J Pathol. 58:51–57. 2007.PubMed/NCBI
|
|
28
|
Delwar ZM, Siden A, Cruz MH and Yakisich
JS: Menadione: Sodium orthovanadate combination eliminates and
inhibits migration of detached cancer cells. ISRN Pharmacol.
2012:3071022012. View Article : Google Scholar
|
|
29
|
Woo ES, Rice RL and Lazo JS: Cell cycle
dependent subcellular distribution of Cdc25B subtypes. Oncogene.
18:2770–2776. 1999. View Article : Google Scholar : PubMed/NCBI
|
